Free Printable Aspiris MDP Follow up Quiz 2

1.

Select your designation

a)

HO

b)

AM

c)

RSM

d)

DGM

2.

Enter your zone name

4 lines

3.

Write down your Region name

4 lines

4.

Enter your employee ID

4 lines

5.

Vilmist contains Vilanterol which is 2400 times more selective to Beta 1 receptor as comapred to Beta 2 .

a)

False

b)

True

6.

Vilmist contains Fluticasone Furoate which has 1.7 times higher ______ binding affinity

a)

Muscarinic receptor

b)

Beta 2 receptor

c)

Gluco corticoid receptor

d)

Leukotriene receptor

7.

Vilmist can be used in which severity of Asthma patients?

a)

Mild

b)

Moderate

c)

Moderate & Severe with comorbidities

d)

Severe

8.

If Beta 1 receptor (cardiac muscle) is activated by LABA, what side effects patients can get - (Multiple options can be correct)

a)

Fluctuation in BP

b)

QT interval prolongation

c)

Tachycardia

d)

Bronchodilation

e)

Bronchoconstriction

9.

Select the points we can use to covert Seroflo 250 DPI prescriber -(Multiple options can be correct)

a)

Vilanterol has faster onset of action 3.45 min vs Salmaterol 13.7 min

b)

Fluticasone Furoate has 3 times higher GR binding affinity

c)

Fluticasone furoate has lower risk of pneumonia

d)

Vilanterol has 24 hrs duration of action vs Salmeterol 12 hrs

10.

Select the right indication for Vimist in COPD as per the latest GINA/GOLD guidelines

a)

In mild COPD

b)

In mild to moderate COPD

c)

In COPD with concomitant Asthma (eos >300 cells)

d)

In COPD with concomitant Asthma (eos<100)

11.

As per latest GINA guidelines, Vilmist can be used in ________ of Asthma

a)

Step 1 & 2

b)

Step 3

c)

Step 4

d)

Step 3 to 5

12.

Select the main outcome of SLS Asthma (Select best 3 options)

a)

Adherence rate was high with FFV i.e 82.4 %

b)

It was a 60 weeks study

c)

Significant 20% reduction in the annual rate of severe exacerbations

d)

25 % more patients improved Asthma control with FFV

13.

The rate of moderate or severe exacerbations was significantly lower, by 8.4%, with FFV. This is the main outcome of which study

a)

SALFORD LUNG STUDY ASTHMA

b)

SALFORD LUNG STUDY COPD

c)

SUMMIT STUDY

d)

NONE

14.

Which of the following is not a competitor of Vilmist

a)

Voltido

b)

Vilor F

c)

Besvil

d)

Esiflo

15.

What is cost of Seroflo 250 DPI vs Vilmist / month

a)

Serolfo 948 Rs vs Vilmist 370 Rs

b)

Serolfo 1000 Rs vs Vilmist 345 Rs

c)

Serolfo 1000 Rs vs Vilmist 475 Rs

d)

None of above

Aspiris MDP Follow up Quiz 2 - Vilmist

Total questions: 15

Worksheet time: 11mins

Similar Resources on Wayground